rxstat › Shortages › Meningococcal Polysaccharide Antigen Group A C W-135 Y

Meningococcal Polysaccharide Antigen Group A C W-135 Y (Menomune-A/C/Y/W-135) shortage status

Discontinued

Source: Health Canada shortage reports · Updated Jul 9, 2026

Meningococcal Polysaccharide Antigen Group A C W-135 Y products have been discontinued in Canada. See the reports below for which products and when.

A vaccine used to help protect against meningococcal disease.

Products affected
0 / 2
Reports on file
3

Reports by product

The DIN is printed on your prescription label.

Resolved
MENOMUNE-A/C/Y/W-135
50 MCG / 0.5 ML 50 MCG / 0.5 ML 50 MCG / 0.5 ML 50 MCG / 0.5 ML · Kit, Powder For Solution · SANOFI PASTEUR LIMITED
DIN 01959018 · ended Mar 29, 2017 · Disruption of the manufacture of the drug.
Discontinued
MENOMUNE-A/C/Y/W-135
50 μG 50 μG 50 μG 50 μG · Powder For Solution · SANOFI PASTEUR LIMITED
DIN 01959018
Discontinued
MENOMUNE-A/C/Y/W-135
500MCG 500MCG 500MCG 500MCG · POWDER FOR SOLUTION · SANOFI PASTEUR LIMITED
DIN 00588490

What's happening

One or more Meningococcal Polysaccharide Antigen Group A C W-135 Y products have been permanently discontinued by their manufacturers. If your product is affected, ask your pharmacist about equivalent products still on the market.

Meningococcal Polysaccharide Antigen Group A C W-135 Y is classified under “BACTERIAL VACCINES” (ATC J07AH).

Recent changes

Common questions

What is Meningococcal Polysaccharide Antigen Group A C W-135 Y used for?

A vaccine used to help protect against meningococcal disease.

When will Meningococcal Polysaccharide Antigen Group A C W-135 Y be back in stock in Canada?

Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.

Why is Meningococcal Polysaccharide Antigen Group A C W-135 Y in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Related drugs (bacterial vaccines)

Boostrix (Pertactin Tetanus Toxoid Filamentous Haemagglutinin Pertussi…) Partial shortage 1 of 1 reported products affected · est. return Aug 31, 2026 Menveo (Corynebacterium Diphtheriae Crm-197 Protein Meningococcal Gr…) No current shortage Prevnar (Corynebacterium Diphtheriae Crm-197 Protein Pneumococcal Pol…) Discontinued 0 of 1 reported products affected Capvaxive (Corynebacterium Diphtheriae Crm-197 Protein Pneumococcal Pol…) No current shortage Hiberix (Haemophilus Influenzae Type B-prp / Tetanus Toxoid Conjugate) Discontinued 0 of 1 reported products affected Menjugate (Meningococcal Group C Oligosaccharide Corynebacterium Diphth…) Discontinued 0 of 2 reported products affected

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.